We are live on ! Find out more
DRIOW

DarioHealth Corp. Warrant
DRIOW

Delisted

DRIOW was delisted on the 4th of March, 2021.

Back to rankings

1 hedge funds and large institutions have $10K invested in DarioHealth Corp. Warrant in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

52% less capital invested

Capital invested by funds: $21K → $10K (-$11K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$588

Top Sellers

Rank Fund Capital Flow
1
WPC
Waters Parkerson & Co
Louisiana
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
Bard Associates
Illinois
$8K – – –
UBS Group
2
UBS Group
Switzerland
$2K +$588 +2,393 +16%
WPC
3
Waters Parkerson & Co
Louisiana
– -$4K -20,000 Closed

DRIOW Hedge Fund Activity: Q2 2018 in Review

1 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q2 2018, worth a combined $10K — down 52% from $21K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DRIOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $588. The largest seller was Waters Parkerson & Co, exiting entirely with an estimated $4K sold.

  • 1 institutional investor held DarioHealth Corp. Warrant (DRIOW) as of Q2 2018, down from 2 in Q1 2018.
  • Funds reported $10K of DarioHealth Corp. Warrant stock for Q2 2018, down 52% quarter-over-quarter.
  • 0 funds opened new DarioHealth Corp. Warrant positions in Q2 2018 and 1 closed out, a net change of -1 holder.
  • The largest DarioHealth Corp. Warrant buyer in Q2 2018 was UBS Group, an estimated $588 added.
  • The largest DarioHealth Corp. Warrant seller in Q2 2018 was Waters Parkerson & Co, an estimated $4K sold.

Based on aggregated 13F filings for Q2 2018.